Biocrossroads News Archives - CEOs of Indiana Corporate Partnership

BioCrossroads 2025 Annual Report: Indiana’s Life Sciences Ecosystem in 2025

Courtney Kerr2026-03-18T19:11:53-04:00March 18, 2026|

Advancing BioCrossroads' 10-Year Strategy INDIANAPOLIS (March 18, 2026)—BioCrossroads today released its 2025 Annual Report, highlighting another landmark year for Indiana’s life sciences ecosystem. The report highlights BioCrossroads’ efforts to support robust talent pipelines, unprecedented economic impact, and national recognition of Indiana’s leadership in life sciences. Indiana remained number one in the nation for life sciences and pharmaceutical exports. The report also highlights continued growth and momentum across the state’s life sciences and healthcare sectors: $102 billion total economic contribution from Indiana’s life sciences industry; 70,000 Hoosiers employed in life sciences across 3,312 establishments; $177,000 average annual wage in life sciences; 386,100 healthcare workers across Indiana; 36 venture capital deals totaling approximately $190 million invested in Indiana life sciences companies in 2025. “By crossing the $100 billion threshold of total economic contribution, Indiana’s life sciences sector has reached a remarkable [...]

CICP Launches Catalyst Scholars Fund to Drive Advanced Chemistry Innovation in Indiana

Courtney Kerr2026-03-05T09:52:48-05:00March 5, 2026|

Indianapolis (March 5, 2026) – The Central Indiana Corporate Partnership (CICP) has announced the launch of the Catalyst Scholars Fund, which marks the first phase of a broader Advanced Chemistry strategy for Indiana. The strategy involves a coordinated effort to position Indiana as the national leader in the development and deployment of technologies needed to reshore and secure critical supply chains for medicines, animal health products, and agricultural inputs, which is a national security priority. The Catalyst Scholars Fund is a five-year initiative to enable Indiana’s leading STEM higher education institutions, including its four R1 research institutions (Indiana University Bloomington, Indiana University Indianapolis, Purdue University and the University of Notre Dame) along with Rose-Hulman Institute of Technology to attract world-class research teams in Advanced Chemistry through strategic cluster and eminent scholar recruitment. The Fund will provide matching support for [...]

BioCrossroads launches online platform for life sciences startups

Courtney Kerr2026-01-22T15:32:56-05:00January 22, 2026|

This post was originally published by Inside Indiana Business. Click here to read the original article. INDIANAPOLIS - BioCrossroads has launched an online platform that aims to serve as “front door” for Indiana’s life sciences startup community. The BioCrossroads Startup Resource Hub is designed to provide startups and entrepreneurs with a wide variety of resources, including funding pathways, regulatory and clinical resources, and ecosystem connections in one place. CEO Vince Wong told Inside INdiana Business that while there has been a proliferation of entrepreneurial support organizations in the state’s life science sector, it has led to a fragmentation of resources available to startups, which can create barriers to growth. “We heard from the entrepreneurial community…and they gave us a message loud and clear that they would love a one-stop shop, a front door to really aggregate and bring together all those resources to [...]

BioCrossroads Launches Startup Hub, a New Centralized Platform for Indiana’s Life Sciences Startup Ecosystem

Courtney Kerr2026-02-18T16:28:45-05:00January 22, 2026|

INDIANAPOLIS [January 22, 2025] – BioCrossroads today officially launched the BioCrossroads Startup Hub, a new, comprehensive ecosystem platform designed to serve as a centralized front door for Indiana’s life sciences startup community. Built as a continually evolving resource, this online hub brings together funding pathways, mentorship, regulatory and clinical resources, startup visibility, and ecosystem connections in one place. The platform targets a longstanding challenge within Indiana’s innovation economy: while the state is home to one of the strongest life sciences ecosystems in the country, the resources that support startups have historically been fragmented across many organizations and websites. That fragmentation can slow momentum for founders, limit visibility for investors, and create unnecessary barriers to growth. The BioCrossroads Startup Hub is designed for the multiple stakeholders critical to a thriving startup ecosystem— researchers and innovators exploring commercialization; investors seeking Indiana-based life [...]

Crossroads Health Ventures Announces First Fund with More Than $21 Million Committed to Strengthen Indiana’s Life Sciences Innovation Pipeline

Courtney Kerr2026-01-21T12:45:06-05:00January 21, 2026|

INDIANAPOLIS (Jan. 21, 2026) – Crossroads Health Ventures (CHV) announced its launch of a new early-stage venture fund created to accelerate the growth of Indiana’s life sciences startups and reinforce the state’s global leadership across human, animal, and plant health innovation. The fund has secured more than $21 million in commitments from strategic and institutional partners such as Eli Lilly and Company, Corteva, Elanco Animal Health, Indiana University, Parkview Health, and the State of Indiana through the Economic Development Corporation (IEDC). CHV will begin deploying capital in early 2026. “Indiana is one of the nation’s strongest and most vibrant life sciences hubs, and Crossroads Health Ventures is an important next step in fueling our state’s innovation economy,” said Vince Wong, President and CEO of BioCrossroads and Crossroads Health Ventures. “With the State of Indiana’s transformational commitment and the leadership of [...]

‘One Health’ to be focus of Life Sciences Summit

Courtney Kerr2025-11-13T15:42:55-05:00November 13, 2025|

This article was originally published by Inside Indiana Business. Click here to read the original article. INDIANAPOLIS - BioCrossroads, the initiative of the Central Indiana Corporate Partnership focused on promoting Indiana’s life sciences sector, is hosting its annual Life Sciences Summit on Thursday. The event, being held at the recently opened Elanco Animal Health global headquarters in downtown Indianapolis, brings together more than 250 leaders to discuss “the most pressing challenges and emerging opportunities” in the life sciences industry. The theme of this year’s summit is “One Health: Indiana’s Blueprint for Global Leadership,” which is a reference to the One Health Innovation District, an emerging industry hub being developed by Elanco, Purdue University and the Indiana Economic Development Corp. The new Elanco headquarters building is the first part of the burgeoning district, plans for which also include a shared-use facility for the three partners. BioCrossroads [...]

BioCrossroads Launches AXIS Mentoring Program, Designed to Strengthen Indiana’s Life Sciences Future

Courtney Kerr2025-08-07T13:23:10-04:00July 22, 2025|

July 2025 marked an exciting milestone for Indiana’s life sciences community with the official launch of AXIS, a revived statewide mentoring program from BioCrossroads. Held at the Indiana Biosciences Research Institute (IBRI), the event brought together innovators, mentors, academic and industry leaders, and rising entrepreneurs—all committed to supporting the next generation of life sciences talent in Indiana. The AXIS Mentoring Program is designed to provide structured, team-based, and conflict-free mentorship to early-stage life sciences entrepreneurs. Drawing from the proven model of MIT’s Venture Mentoring Service (VMS), the program builds a strong support system for individuals navigating the challenges of scientific innovation, commercialization, and startup growth. Emily Atkinson, Senior Director of Innovation at BioCrossroads, emphasized the importance of the moment. “The launch of AXIS marks a new chapter for Indiana’s life sciences ecosystem. By bringing together world-class mentors and passionate entrepreneurs [...]

Indiana Officially Designated as the Radiopharmaceutical Capital of the World®

Courtney Kerr2025-07-21T15:25:56-04:00July 21, 2025|

National designation reinforces Indiana’s global leadership in radiopharmaceutical innovation, manufacturing, and supply chain infrastructure. INDIANAPOLIS (July 21, 2025) — Indiana has secured the title of Radiopharmaceutical Capital of the World® from the U.S. Patent and Trademark Office, solidifying the state's global leadership in the rapidly growing field of precision medicine. Powered by a robust and highly specialized talent pool, unmatched logistics infrastructure, world-class research institutions, and geographically central location, Indiana serves as a critical nucleus for the rapidly growing radiopharmaceutical sector that is transforming oncology for patients and providers. Radiopharmaceuticals are drugs that contain, among other ingredients, radioisotopes. Depending on the type of radiation those radioisotopes produce, they can be used to diagnose or treat several medical conditions, including cancer and hyperthyroidism. Beyond its deep FDA-savvy talent pool, Indiana’s radiopharmaceutical leadership is anchored by specialized isotope production facilities, integrated [...]

Central Indiana Corporate Partnership announces senior leadership appointments across BioCrossroads, Conexus Indiana and TechPoint

Ronnetta Spalding2024-12-19T00:27:36-05:00December 12, 2024|

INDIANAPOLIS – The Central Indiana Corporate Partnership (CICP), alongside its branded initiatives BioCrossroads, Conexus Indiana and TechPoint, today announces the appointment of three senior leaders who will play pivotal roles in shaping the future of Indiana’s life sciences, advanced manufacturing and logistics and technology sectors. Douglas Kiehl, Patrick “PJ” McGrew and Casey Osterkamp joined BioCrossroads, Conexus Indiana and TechPoint, respectively, in senior leadership roles on December 10. “As we ensure the strength of Indiana’s advanced industries, these strategic hires underscore our commitment to building a thriving, innovative economy,” said Melina Kennedy, CEO of the Central Indiana Corporate Partnership. “Doug, PJ and Casey each bring a depth of expertise that will help us tackle workforce challenges, advance technological adoption and foster cross-sector collaboration. Together, they will elevate our efforts to position Indiana as a global leader in innovation and talent [...]

BioCrossroads announces the 2024 Indiana Life Sciences Summit, “Transforming Healthcare: Indiana’s Role in Revolutionizing Diabetes and Obesity Management”

Ronnetta Spalding2024-09-12T10:55:22-04:00July 16, 2024|

FOR IMMEDIATE RELEASE INDIANAPOLIS – BioCrossroads is excited to announce the annual Indiana Life Sciences Summit, scheduled for November 7, 2024, at the Biltwell Event Center in Indianapolis. The Summit will focus on "Transforming Healthcare: Indiana’s Role in Revolutionizing Diabetes and Obesity Management,” highlighting Indiana's significant impact on healthcare, particularly in the development of GLP-1 therapies, which are revolutionizing diabetes and obesity care, and the opportunities that lie ahead for continued advancement of future therapies. GLP-1 therapies, developed and delivered through the relentless efforts of Indiana's researchers and companies, have emerged as vital tools in managing obesity and diabetes, offering new hope to millions worldwide. Nationwide, more than 38 million (1) Americans are living with diabetes, with obesity being linked to as many as 53 percent of new cases of type 2 diabetes each year (2). In Indiana, more [...]

MAIN MENU

IMPORTANT LINKS

INITIATIVES